Source Feed: The Globe and Mail
Author: Nicole Ireland
Publication Date: August 17, 2026 - 12:58
Stay informed
Unpublished Opinions
Health Canada approves drug for hot flashes in breast cancer patients
August 17, 2026
Elinzanetant, also known by the brand name Lynkuet, has shown effectiveness in reducing hot flashes and night sweats in breast cancer patients whose estrogen-suppressing treatment has put them into menopause.
Maureen Basnicki wants Canadians to redefine the day and celebrate service men and women including those who supported the victims in the aftermath of the terrorist attack.
September 11, 2026 - 22:40 | Catherine McDonald | Global News - Ottawa
September 11, 2026 - 21:33 | Lindsay Jones | The Globe and Mail
September 11, 2026 - 21:07 | Nathan VanderKlippe | The Globe and Mail




Comments
Be the first to comment